002082.SZ
Wanbangde Pharmaceutical Holding Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.44
−3.77%Year over year
Reported trailing growth
- Revenue
- -11.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +283.3%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -14.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +888.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026